Author: [AUTHOR] Published on 7/1/2019 12:00:00 AM
Guang Yang, MS, University of Florida, Gainesville, FL
After joining the Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida in 2015, Guang joined Dr. Gong's lab. Dr. Gong's lab focuses on pharmacogenomics research and requires a background of clinical and translational pharmacology. As Guang's mentor, Dr. Gong encouraged him to attend the Annual Meeting as a way to improve his understanding of clinical and translational pharmacology.
In Guang's view, clinical pharmacology and translational medicine conduct the outcomes of bench research to human patients. The ultimate purpose of clinical pharmacology and translational medicine is to improve human health: “Patients receive better and more effective treatment based on clinical and translational research.” Guang is most interested in the study of pharmacogenomics. The aim of this study for him is to enable the right patient getting the right drug at the right dose. Specifically, his study focuses on identifying the pharmacogenomic markers of osteonecrosis of the jaw induced by bisphosphonates agents.
The first Annual Meeting Guang attended was in 2017 in Washington, DC. He attended in an effort to learn more about clinical and translational pharmacology on a deeper level. ASCPT provided him with an “outstanding opportunity to talk with other members and learn from them in the field of Biomarkers and Translational Research.” For the future, he hopes for the opportunity to meet peers and share ideas about research and discovery. Being a member of ASCPT allows him to stay up‐to‐date with the recent advances in translational research. He also takes advantage of the ASCPT webinars.
Guang has been a member of ASCPT since 2016.